批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
提交状态日期 | 提交号 | 审批结论 | 申请内容分类 | 审评优先级;罕用药状态 | 通知信、审评文件、说明书、包装标签 | 备注 |
2021/02/22 |
SUPPL-52(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2020/04/29 |
SUPPL-51(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2019/08/09 |
SUPPL-50(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2018/12/21 |
SUPPL-49(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2018/12/21 |
SUPPL-48(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2016/12/13 |
SUPPL-47(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2014/11/26 |
SUPPL-45(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2013/12/30 |
SUPPL-43(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2013/03/21 |
SUPPL-42(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2012/10/18 |
SUPPL-39(补充) |
Approval |
Labeling |
UNKNOWN
|
|
|
2012/09/27 |
SUPPL-40(补充) |
Approval |
Labeling |
UNKNOWN
|
|
|
2012/03/26 |
SUPPL-36(补充) |
Approval |
Efficacy |
STANDARD
|
|
|
2011/12/16 |
SUPPL-37(补充) |
Approval |
Labeling |
UNKNOWN
|
|
|
2011/04/27 |
SUPPL-34(补充) |
Approval |
Labeling |
UNKNOWN
|
|
|
2010/08/10 |
SUPPL-31(补充) |
Approval |
Labeling |
UNKNOWN
|
|
|
2010/04/26 |
SUPPL-29(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2009/08/19 |
SUPPL-28(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2009/01/27 |
SUPPL-27(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2008/04/24 |
SUPPL-26(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2008/04/21 |
SUPPL-25(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2008/03/07 |
SUPPL-23(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2007/04/13 |
SUPPL-16(补充) |
Approval |
Efficacy |
UNKNOWN
|
|
|
2006/12/08 |
SUPPL-19(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2006/05/19 |
SUPPL-18(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2005/11/30 |
SUPPL-14(补充) |
Approval |
Efficacy |
UNKNOWN
|
|
|
2005/07/27 |
SUPPL-12(补充) |
Approval |
Efficacy |
UNKNOWN
|
|
|
2005/06/27 |
SUPPL-17(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2005/05/26 |
SUPPL-15(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2004/12/29 |
SUPPL-11(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2004/11/15 |
SUPPL-10(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2003/12/19 |
SUPPL-7(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2003/10/02 |
SUPPL-5(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2002/12/31 |
SUPPL-3(补充) |
Approval |
Efficacy |
UNKNOWN
|
|
|
2002/07/26 |
ORIG-1(原始申请) |
Approval |
Type 3 - New Dosage Form |
STANDARD
|
|
|
与本品相关的专利信息(来自FDA橙皮书Orange Book)
与本品治疗等效的药品
活性成分:MONTELUKAST SODIUM 剂型/给药途径:GRANULE;ORAL 规格:EQ 4MG BASE/PACKET 治疗等效代码:AB
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
021409 |
001 |
NDA |
SINGULAIR |
MONTELUKAST SODIUM |
GRANULE;ORAL |
EQ 4MG BASE/PACKET |
Prescription |
Yes |
Yes |
AB |
2002/07/26
|
ORGANON |
090955 |
001 |
ANDA |
MONTELUKAST SODIUM |
MONTELUKAST SODIUM |
GRANULE;ORAL |
EQ 4MG BASE/PACKET |
Discontinued |
No |
No |
AB |
2012/08/03
|
TEVA PHARMS |
202906 |
001 |
ANDA |
MONTELUKAST SODIUM |
MONTELUKAST SODIUM |
GRANULE;ORAL |
EQ 4MG BASE/PACKET |
Prescription |
No |
No |
AB |
2012/09/17
|
DR REDDYS LABS LTD |
203438 |
001 |
ANDA |
MONTELUKAST SODIUM |
MONTELUKAST SODIUM |
GRANULE;ORAL |
EQ 4MG BASE/PACKET |
Prescription |
No |
No |
AB |
2015/07/31
|
AJANTA PHARMA LTD |
210431 |
001 |
ANDA |
MONTELUKAST SODIUM |
MONTELUKAST SODIUM |
GRANULE;ORAL |
EQ 4MG BASE/PACKET |
Prescription |
No |
No |
AB |
2018/07/31
|
TORRENT |
213471 |
001 |
ANDA |
MONTELUKAST SODIUM |
MONTELUKAST SODIUM |
GRANULE;ORAL |
EQ 4MG BASE/PACKET |
Prescription |
No |
No |
AB |
2020/02/18
|
AUROBINDO PHARMA LTD |